olivLaw · US equity research
Central Garden & Pet Company CENT
Wholesale-Miscellaneous Nondurable Goods · SIC 5190 · Vertical: Wholesale — nondurable goods (SIC 51xx)
Central Garden & Pet is a leading U.S. pet and garden company selling branded and private label products through large retail chains. The company is in a transition year: it exited its pet distribution business, announced the majority acquisition of Germany's TRIXIE, and raised its profit outlook per share.
At the close of 04 Nov 2026, Central Garden & Pet Company (CENT) stock was 48.38 USD (+4.38% on the day), with market capitalisation 592.5 m USD, P/E 18.0 on diluted EPS of 2.68 USD over the last 12 months, beta 0.52, 52-week range 30.47–48.38 USD. Latest reported quarter (Q3 2026): revenue of 882.4 m USD (−8.2% YoY), net income of 89.9 m USD (−5.4% YoY), diluted EPS 1.45 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 77.0
- overbought (≥ 70)
- Bollinger (20, 2)
- 39.11 – 48.30
- above the upper band · %B 1.01 · band width 21.0%
- SMA 50 / 200
- 41.88 / 40.13
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 1.59 / 1.16
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +21.9% | −1.1% | +23.0 pp | — |
| 3 months | +9.8% | −0.5% | +10.3 pp | — |
| 6 months | +31.4% | +4.4% | +27.0 pp | — |
| Year to date | +50.5% | +12.3% | +38.2 pp | — |
| 1 year | +57.5% | +13.5% | +43.9 pp | −1.2% |
| 3 years | +37.8% | +76.4% | −38.7 pp | +2.3% |
| 5 years | +10.8% | +63.7% | −52.8 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 27 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 669.5 m | 656.4 m | 833.5 m | 960.9 m | 678.2 m | 617.4 m | 906.2 m | 882.4 m |
| Cost of revenue | 500.5 m | 460.7 m | 560.5 m | 628.9 m | 481.6 m | 426.8 m | 606.6 m | 565.4 m |
| Gross profit | 169.0 m | 195.7 m | 273.1 m | 332.0 m | 196.5 m | 190.6 m | 299.6 m | 316.9 m |
| SG&A | 201.4 m | 167.7 m | 179.8 m | 196.9 m | 202.9 m | 174.1 m | 185.6 m | 191.1 m |
| Operating income | -32.4 m | 28.0 m | 93.3 m | 135.1 m | -6.4 m | 16.5 m | 113.9 m | 125.8 m |
| Depreciation & amortisation | 22.7 m | 21.9 m | 20.6 m | 21.5 m | 20.8 m | 20.7 m | 20.7 m | 19.6 m |
| Interest expense | 14.1 m | 14.5 m | 14.5 m | 14.4 m | 14.4 m | 14.5 m | 14.1 m | 14.3 m |
| Pre-tax income | -45.0 m | 18.5 m | 84.7 m | 127.4 m | -13.9 m | 8.9 m | 104.5 m | 119.6 m |
| Income tax | -10.6 m | 4.4 m | 19.9 m | 31.9 m | -3.4 m | 2.1 m | 24.5 m | 29.6 m |
| Net income | -34.2 m | 14.0 m | 63.6 m | 95.0 m | -9.8 m | 6.8 m | 79.4 m | 89.9 m |
| Diluted EPS | -0.51 ≈ | 0.21 | 0.98 | 1.52 | -0.16 ≈ | 0.11 | 1.28 | 1.45 |
| Operating cash flow | 203.1 m | -68.8 m | -46.9 m ≈ | 265.5 m ≈ | 182.7 m | -70.2 m | -49.6 m ≈ | 327.5 m ≈ |
| Capex | 10.0 m | 6.1 m | 10.7 m ≈ | 13.8 m ≈ | 10.8 m | 10.8 m | 10.5 m ≈ | 12.6 m ≈ |
| Share repurchases | 9.3 m | 54.0 m | 44.2 m ≈ | 56.5 m ≈ | 332.0 k | 20.0 m | 7.9 m ≈ | 951.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 85 percentile of its own 39-quarter history (min 10.5, median 14.1, max 22.6; quarters with earnings only).
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2 bn | 2.4 bn | 2.7 bn | 3.3 bn | 3.3 bn | 3.3 bn | 3.2 bn | 3.1 bn |
| Revenue YoY | +7.8% | +7.6% | +13.1% | +22.6% | +1.1% | −0.9% | −3.3% | −2.2% |
| Net income | 123.6 m | 92.8 m | 120.7 m | 151.7 m | 152.2 m | 125.6 m | 108.0 m | 162.8 m |
| Net income YoY | +56.8% | −24.9% | +30.1% | +25.7% | +0.3% | −17.4% | −14.1% | +50.8% |
| Diluted EPS | 2.32 | 1.61 | 2.20 | 2.75 | 2.24 | 1.88 | 1.62 | 2.55 |
| Diluted EPS YoY | +52.6% | −30.6% | +36.6% | +25.0% | −18.5% | −16.1% | −13.8% | +57.4% |
| net % | 5.6% | 3.9% | 4.5% | 4.6% | 4.6% | 3.8% | 3.4% | 5.2% |
| Free cash flow | 76.3 m | 173.4 m | 221.2 m | 170.5 m | -149.2 m | 327.7 m | 351.8 m | 291.1 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 27 Sept 2025
- Cash
- 882.5 m USD
- Financial debt
- 1.2 bn USD
- Net debt
- 309.2 m USD
- Equity
- 1.6 bn USD
- Total assets
- 3.6 bn USD
- Debt / equity
- 0.75x
- Current ratio
- 3.67x
- ROE
- 10.4%
- ROA
- 4.5%
- FCF margin
- 9.3%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 2.7 bn | 3.3 bn | 3.3 bn | 3.3 bn | 3.2 bn | 3.1 bn | SEC (XBRL)· 26 Nov 2025verified |
| Cost of revenue | 1.9 bn | 2.3 bn | 2.3 bn | 2.4 bn | 2.3 bn | 2.1 bn | SEC (XBRL)· 26 Nov 2025verified |
| Gross profit | 796.6 m | 970.9 m | 992.3 m | 946.8 m | 943.7 m | 997.3 m | SEC (XBRL)· 26 Nov 2025verified |
| SG&A | 598.6 m | 716.4 m | 732.3 m | 736.2 m | 758.3 m | 747.3 m | SEC (XBRL)· 26 Nov 2025verified |
| Operating income | 198.0 m | 254.5 m | 260.0 m | 210.6 m | 185.4 m | 250.0 m | SEC (XBRL)· 26 Nov 2025verified |
| Depreciation & amortisation | 55.4 m | 74.7 m | 80.9 m | 87.7 m | 90.8 m | 84.9 m | SEC (XBRL)· 26 Nov 2025verified |
| EBITDA | 253.3 m ≈ | 329.2 m ≈ | 341.0 m ≈ | 298.3 m ≈ | 276.2 m ≈ | 334.9 m ≈ | SEC (XBRL)· 26 Nov 2025derived |
| Interest expense | 44.0 m | 58.6 m | 58.3 m | 57.0 m | 57.5 m | 57.7 m | SEC (XBRL)· 26 Nov 2025verified |
| Pre-tax income | 153.7 m | 194.8 m | 198.9 m | 162.4 m | 142.4 m | 216.8 m | SEC (XBRL)· 26 Nov 2025verified |
| Income tax | 32.2 m | 42.0 m | 46.2 m | 36.3 m | 33.1 m | 52.8 m | SEC (XBRL)· 26 Nov 2025verified |
| Net income | 120.7 m | 151.7 m | 152.2 m | 125.6 m | 108.0 m | 162.8 m | SEC (XBRL)· 26 Nov 2025verified |
| Diluted EPS | 2.20 | 2.75 | 2.24 | 1.88 | 1.62 | 2.55 | SEC (XBRL)· 26 Nov 2025verified |
| Weighted average diluted shares | 54.7 m | 55.2 m | 68.0 m | 66.8 m | 66.9 m | 63.8 m | SEC (XBRL)· 26 Nov 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 652.7 m | 426.4 m | 177.4 m | 488.7 m | 753.6 m | 882.5 m | SEC (XBRL)· 26 Nov 2025verified |
| Receivables | 391.8 m | 385.4 m | 376.8 m | 332.9 m | 326.2 m | 325.3 m | SEC (XBRL)· 26 Nov 2025verified |
| Inventories | 439.6 m | 685.2 m | 938.0 m | 838.2 m | 757.9 m | 722.1 m | SEC (XBRL)· 26 Nov 2025verified |
| Current assets | 1.5 bn | 1.5 bn | 1.6 bn | 1.7 bn | 1.9 bn | 2.0 bn | SEC (XBRL)· 26 Nov 2025verified |
| Property, plant & equipment, net | 244.7 m | 328.6 m | 397.0 m | 391.8 m | 379.2 m | 363.2 m | SEC (XBRL)· 26 Nov 2025verified |
| Goodwill | 290.0 m | 369.4 m | 546.4 m | 546.4 m | 551.4 m | 554.7 m | SEC (XBRL)· 26 Nov 2025verified |
| Intangibles (excl. goodwill) | 134.9 m | 134.4 m | 543.2 m | 497.2 m | 473.3 m | 447.6 m | SEC (XBRL)· 26 Nov 2025verified |
| Total assets | 2.3 bn | 3.1 bn | 3.3 bn | 3.4 bn | 3.6 bn | 3.6 bn | SEC (XBRL)· 26 Nov 2025verified |
| Accounts payable | 205.2 m | 245.5 m | 215.7 m | 190.9 m | 212.6 m | 234.6 m | SEC (XBRL)· 26 Nov 2025verified |
| Short-term debt | 97.0 k | 1.1 m | 317.0 k | 247.0 k | 239.0 k | 62.0 k | SEC (XBRL)· 26 Nov 2025verified |
| Long-term debt | 694.0 m | 1.2 bn | 1.2 bn | 1.2 bn | 1.2 bn | 1.2 bn | SEC (XBRL)· 26 Nov 2025verified |
| Current liabilities | 440.3 m | 522.3 m | 465.9 m | 458.0 m | 515.4 m | 538.8 m | SEC (XBRL)· 26 Nov 2025verified |
| Equity | 1.1 bn | 1.2 bn | 1.3 bn | 1.5 bn | 1.6 bn | 1.6 bn | SEC (XBRL)· 26 Nov 2025verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 264.3 m | 250.8 m | -34.0 m | 381.6 m | 394.9 m | 332.5 m | SEC (XBRL)· 26 Nov 2025verified |
| Capex | 43.1 m | 80.3 m | 115.2 m | 54.0 m | 43.1 m | 41.4 m | SEC (XBRL)· 26 Nov 2025verified |
| Free cash flow | 221.2 m ≈ | 170.5 m ≈ | -149.2 m ≈ | 327.7 m ≈ | 351.8 m ≈ | 291.1 m ≈ | SEC (XBRL)· 26 Nov 2025derived |
| Investing cash flow | -48.1 m | -899.4 m | -143.0 m | -34.6 m | -105.2 m | -44.9 m | SEC (XBRL)· 26 Nov 2025verified |
| Financing cash flow | -60.6 m | 420.5 m | -66.8 m | -37.6 m | -25.4 m | -156.6 m | SEC (XBRL)· 26 Nov 2025verified |
| Share repurchases | 59.1 m | 27.9 m | 62.3 m | 37.2 m | 24.1 m | 155.1 m | SEC (XBRL)· 26 Nov 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 68 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 592.5 m USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet67
- Valuation85
- Quality84
- Growth15
- Returns70
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 29.59 – 1,325.21 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)562.81 – 1,325.21 (Mid 786.81)WACC 6.1% · starting FCFF 389.1 m USD · terminal value share of EV 84%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: no growth between −30% and +40% justifies the price
- Peers: EV/EBITDA166.96 – 407.03 (Mid 259.97)18 companies used · median multiple 10.2x · quartiles 6.8x – 15.6xASH, CAH, CAPL, CHEF, CHSCL, COR, DIT, DPZ, HLF, HWKN, MCK, MMLP, NUS, SEB, SYY, UNFI, USFD, VSTS
- Peers: P/E29.59 – 95.21 (Mid 62.72)18 companies used · median multiple 23.4x · quartiles 11.0x – 35.5xANDE, CAH, CAPL, CHEF, COR, DIT, DPZ, EDUC, GLP, HLF, HWKN, MCK, PFGC, SEB, SYY, UNFI, USFD, WEYS
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 68/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 9.5% | 73 (vs peers) | 11% |
| Net margin · Quality | 5.4% | 87 (vs peers) | 7% |
| FCF conversion · Quality | 207.8% | 100 (on a fixed band) | 7% |
| Revenue CAGR 3Y · Growth | -2.1% | 0 (on a fixed band) | 9% |
| EPS CAGR 3Y · Growth | 4.4% | 29 (on a fixed band) | 9% |
| Net debt / EBITDA · Balance sheet | 0.6x | 68 (vs peers) | 11% |
| Interest coverage · Balance sheet | 4.4x | 44 (on a fixed band) | 7% |
| Current ratio · Balance sheet | 3.8x | 100 (on a fixed band) | 4% |
| P/E (TTM) · Valuation | 18.0x | 62 (vs peers) | 11% |
| EV/EBITDA · Valuation | 2.4x | 95 (vs peers) | 11% |
| FCF yield · Valuation | 58.3% | 100 (on a fixed band) | 9% |
| Shareholder yield (distributions) · Returns | 4.9% | 70 (on a fixed band) | 7% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet67/100 · 3/3 factors with a value
- Growth15/100 · 2/2 factors with a value
- Quality84/100 · 3/3 factors with a value
- Returns· partial70/100 · 1/2 factors with a value
- Valuation85/100 · 3/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Central Garden & Pet Company (CENT). Latest full fiscal year: 2025; data up to 2026-06-27.
Figures computed from the financial statements: revenue 3.1 bn USD in 2025; YoY growth -2.2%; net margin 5.4%; ROE 10.0%; net debt/EBITDA 0.6x.
The estimated value range is 166.96–407.03 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 259.97 USD, the price of 48.38 USD leaves a potential of 437.3% (value / price − 1) and a margin of safety of 81.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 68/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: returns. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 9.5%
- Net margin: 5.4%
- FCF conversion: 207.8%
- Current ratio: 3.8x
- EV/EBITDA: 2.4x
- FCF yield: 58.3%
- Shareholder yield (distributions): 4.9%
- The price is below the estimated value range
What contradicts it
- Revenue CAGR 3Y: -2.1%
- EPS CAGR 3Y: 4.4%
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): Payout ratio (FCF).
Versus the vertical median
Wholesale — nondurable goods (SIC 51xx) · same major group (2-digit SIC) · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MCKMcKESSON CORPORATION | 123.5 bn | 27.5 | — | 1.1% | +12.4% | +21% / +127% |
| CORCencora, Inc. | 67.6 bn | 26.3 | 104.3% | 0.8% | +9.3% | −4% / +74% |
| CAHCardinal Health, Inc. | 60.9 bn | 36.2 | — | 0.7% | +14.2% | +23% / +145% |
| SYYSysco Corporation | 37.9 bn | 20.5 | 59.1% | 2.1% | +3.9% | +1% / +7% |
| USFDUs Foods Holding Corp. | 23.8 bn | 33.8 | 16.4% | 1.8% | +4.1% | +40% / +151% |
| PFGCPerformance Food Group Company | 17.3 bn | 43.7 | 8.2% | 0.6% | +7.2% | +13% / +68% |
| DPZDomino’s Pizza, Inc. | 11.2 bn | 19.3 | — | 11.9% | +5.0% | −19% / −13% |
| CHEFChefs’ Warehouse, Inc. | 4.6 bn | 46.5 | 16.2% | 2.3% | +9.4% | +74% / +297% |
| ASHAshland Inc. | 3.5 bn | 126.3 | 2.8% | 2.8% | −13.7% | +44% / −4% |
| SEBSeaboard Corporation | 3.3 bn | 5.9 | 10.7% | 5.3% | +7.1% | −26% / −2% |
| HWKNHawkins, Inc. | 3.2 bn | 37.9 | 16.0% | 7.5% | +11.2% | +20% / +154% |
| UNFIUnited Natural Foods, Inc. | 2.9 bn | 36.0 | 5.3% | 0.3% | −2.0% | +29% / +232% |
| VSTSVestis Corp | 2.0 bn | — | -0.6% | -0.2% | −2.5% | +128% / −19% |
| WKCWorld Kinect Corporation | 1.9 bn | — | -11.5% | -0.4% | −12.5% | +64% / +81% |
| ANDEAndersons, Inc. | 1.9 bn | 9.3 | 16.1% | 1.8% | −2.2% | +7% / +11% |
| HLFHerbalife Ltd. | 1.6 bn | 9.1 | — | 3.4% | +0.9% | +20% / +19% |
| GLPGlobal Partners LP | 1.5 bn | 7.6 | — | 0.9% | +8.1% | −1% / +19% |
| CAPLCrossamerica Partners LP | 773.8 m | 16.1 | — | 1.2% | −10.6% | −1% / −15% |
| WEYSWeyco Group, Inc. | 616.9 m | 17.8 | 13.8% | 12.4% | −4.9% | +116% / +119% |
| MGPIMgp Ingredients, Inc. | 364.2 m | — | -34.5% | -51.4% | −23.8% | −25% / −80% |
| NUSNu Skin Enterprises, Inc. | 242.9 m | — | -32.5% | -15.7% | −14.3% | −50% / −71% |
| PTLEPTL Limited | 121.4 m | — | -24.8% | -1.6% | −27.0% | −30% / unavailable |
| HFFGHf Foods Group Inc. | 80.3 m | — | -15.5% | -2.8% | +2.2% | −41% / −69% |
| BANLCbl International Limited | 80.0 m | — | -14.0% | -0.6% | −9.1% | −48% / −86% |
| MMLPMartin Midstream Partners L.P. | 77.1 m | — | — | -1.4% | +1.2% | −25% / −24% |
1- and 3-year price returns: for CENT from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 135.10 Total return 179% · Per year 179% | 239.65 Total return 395% · Per year 395% | 362.11 Total return 648% · Per year 648% |
| 3 years | 114.20 Total return 136% · Per year 33% | 229.52 Total return 374% · Per year 68% | 383.14 Total return 692% · Per year 99% |
| 5 years | 96.54 Total return 100% · Per year 15% | 219.82 Total return 354% · Per year 35% | 405.39 Total return 738% · Per year 53% |
- Exit P/E± 57.38
- Net margin± 40.17
- Annual revenue growth± 35.21
- Annual dilution± 3.38
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Central Garden & Pet is a leading U.S. pet and garden company selling branded and private label products through large retail chains. The company is in a transition year: it exited its pet distribution business, announced the majority acquisition of Germany's TRIXIE, and raised its profit outlook per share.
SWOT
Strengths
- The company has recognized brands in many categories and a strong position with major retailers, which gives it visibility and commercial weight.
- An integrated network of manufacturing, sales and logistics enables efficient delivery and rapid product launches, including for acquired brands.
- The balance sheet and liquidity provide flexibility for acquisitions and investment, and gross margin has improved in recent periods.
Weaknesses
- Garden sales are highly seasonal, and working capital needs peak in the second quarter, which can strain financing.
- The company depends on a few large customers, creating concentration risk and strong bargaining power on their side.
- Costs of seeds and grains are volatile, and purchase contracts cover only part of requirements.
Opportunities
- The TRIXIE acquisition could extend the presence in Europe and create a platform in a fragmented regional pet market.
- Growth in e-commerce and premium products offers room for revenue growth in categories with better margins.
- Continuing the cost reduction program could improve margins and long-term profitability.
Threats
- Trade tariffs and a broader trade war could raise import costs and reduce product competitiveness.
- A decline in discretionary consumer spending or a recession could reduce sales, especially in durable categories.
- Strong competition in online channels and promotional pressure at retail could affect prices and margins.
Risks
- Tariffs and supply chainhigh
Tariffs on imports could raise the cost of products made in other countries. The company has noted that part of its materials come from China, Brazil and Mexico 1.
- Seasonality and weathermedium
Garden sales depend on weather and are concentrated in a few months. Unfavorable conditions could reduce sales and profitability of the segment.
- Reliance on large customershigh
A significant share of sales comes from a few large retailers. Losing a customer or a difficult renegotiation could have a material impact.
- Integration of TRIXIEmedium
The acquisition is subject to regulatory approvals and closing conditions. Integrating a large European company could delay the announced benefits or bring unexpected costs.
- Seed and grain pricesmedium
Seed and grain prices are volatile, and price declines have in the past led to inventory write-downs. The risk persists if the market remains oversupplied.
Investment thesis
What would need to be true (bull case)
- If gross margins keep improving and organic growth stays positive, the company could sustain profitability even in a cautious consumer environment. The raised profit outlook per share signals confidence in execution 3.
- The TRIXIE acquisition could turn the company into a global pet player with a consolidated European presence and mostly own-brand sales 3.
- Leading positions in several market categories and relationships with large retailers give a scale advantage that smaller competitors may find hard to match.
What would break the thesis
- Sales fell in fiscal 2025 and in the third quarter of fiscal 2026, and organic growth could remain modest if consumer demand cools 12.
- Tariffs and energy costs could compress margins, especially if the company cannot pass cost increases on to customers.
- Buying a large European company involves significant cash payment and integration risk, and the debt level could limit financial flexibility.
What to watch
- Trend of gross margin and organic sales growth in the Pet segmentQ4 2026
- Completion of the TRIXIE acquisition and regulatory approvalsfirst half of fiscal 2027
- Delivery of the raised non-GAAP EPS outlook for fiscal 2026Q4 2026
- Level of tariffs and their effect on import costs2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Central Garden & Pet Company ('Central') presents itself as a market leader in the U.S. pet and garden industries, with more than forty years of activity. The company operates through two reportable segments, Pet and Garden. In fiscal 2025, consolidated net sales were 3.1 billion USD 1 and operating income was 250 million USD 1, while the Central to Home strategy aims at organic growth, acquisitions and cost reduction.
The business model combines well-known owned brands such as Nylabone, Kaytee, Farnam, Aqueon and Pennington with private label products and the distribution of third-party brands. The company manufactures most branded products in U.S. facilities, supplemented by contract manufacturing and plants in Canada and Mexico 1. This integrated sales and logistics network lets it deliver quickly to mass merchants and independent retailers.
Segments
Garden
The Garden segment includes lawn seed, vegetable and flower packet seed, wild bird feed, herbicides, insecticides, fertilizers and live plants. Net sales were about 1.3 billion USD in fiscal 2025 1, and the business is strongly seasonal, with most sales in spring and summer 1. In the third quarter of fiscal 2026 sales rose 3% year on year 3.
Market context
Packaged Facts estimates U.S. retail sales of pet categories will total about 158 billion USD in 2025, of which about 40 billion USD falls in the categories where the company competes 1. The pet supplies market is highly fragmented, with more than 2,500 manufacturers 1, many of which rely on distributors such as Central to reach regional chains and independent stores.
Garden demand depends on weather and season, concentrated in spring and summer. The company focuses on growth in higher-margin categories, e-commerce and building its position in Europe through the TRIXIE acquisition 23.
Trends
- Growth of online retailmixed
Shoppers increasingly use online channels, and specialty stores face strong competition. Central invests in digital capabilities and direct-to-consumer sales, which could support volumes if execution holds.
- Humanization and premiumization of petstailwind
More owners regard their animal as a family member and buy premium products for health and wellbeing. This trend supports long-term category growth, especially for brands with strong positions.
- Tariff and cost pressureheadwind
Tariffs imposed by the U.S. administration may raise import costs, and consumer demand for discretionary durable goods has weakened in some categories. If higher costs cannot be passed on to customers, margins could be affected.
- Retail consolidationmixed
Large distributors such as Walmart and Home Depot account for a big share of sales, increasing their bargaining power. At the same time, close relationships with these customers give the company a solid sales base.
Competitive position
The market is fragmented, and Central competes with many niche manufacturers and with companies offering multiple brands in pet and garden. The sources describe a market where only about two dozen companies hold a solid multi-category presence 1, which makes shelf position with large retailers decisive.
Competition also comes from pure-play online channels, which are gaining share, and from specialty chains. The company responds with strong brands, its distribution network and partnerships with distributors to defend its position 12.
- Petco, Pet Supplies Plus and PetSmart
National specialty pet retail chains with thousands of locations that compete for shelf space and for pet segment customers.
- Chewy
Online pet specialty retailer using unlimited digital shelf space, which influences how products are distributed.
- Numerous pet supplies manufacturers
A fragmented market with many smaller producers competing in narrow categories, sometimes relying on distributors such as Central.
- Lawn and garden consumables suppliers
Competitors in the Garden segment supplying seed, fertilizer and herbicides, with price pressure linked to seasonal demand.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Central Garden & Pet (CENT) Raises Guidance Even As Sales SlideYahoo Finance — News · 03 Sept 2026 · EN
- Central Garden & Pet Chairman Sells 3,900 Shares for $152,100Yahoo Finance — News · 29 Aug 2026 · EN
The latest news item in our archive is from 03 Sept 2026; the newest SEC filing is from 22 Sept 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Current report22 Sept 2026Departure or appointment of officers
- Quarterly report06 Aug 2026
- Current report05 Aug 2026Results of operations · Financial statements and exhibits
- Current report27 Jul 2026Other events · Financial statements and exhibits
- Quarterly report07 May 2026
- Current report06 May 2026Results of operations · Financial statements and exhibits
- Current report18 Feb 2026Departure or appointment of officers · Shareholder vote · Other events · Financial statements and exhibits
- Quarterly report05 Feb 2026
- Current report04 Feb 2026Results of operations · Financial statements and exhibits
- Proxy statement22 Dec 2025
Sources
- [1] Form 10-K, fiscal year ended 2025-09-27 · SEC / Central Garden & Pet Company · 26 Nov 2025
- [2] Form 10-Q, quarter ended 2026-06-27 · SEC / Central Garden & Pet Company · 06 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Central Garden & Pet Company · 05 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.